AKANTIOR

This brand name is authorized in Austria, Estonia, Finland, Lithuania

Active ingredients

The drug AKANTIOR contains one active pharmaceutical ingredient (API):

1 Polihexanide
UNII 322U039GMF - POLIHEXANIDE

Polihexanide acts on both the active trophozoite and dormant cystal forms of Acanthamoeba. Polihexanide is a polycationic polymer composed of hexamethylene biguanide units and has a dual-targeted mechanism of action that involves disruption of Acanthamoeba cell membranes and DNA binding.

Read about Polihexanide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AKANTIOR Eye drops European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01AX24 S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AX Other antiinfectives
Discover more medicines within S01AX24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 3091643, 3091654, 3091665
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 473490
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1100813, 1100814, 1100815

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.